{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T15:23:22Z","timestamp":1772119402385,"version":"3.50.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2023,6,26]],"date-time":"2023-06-26T00:00:00Z","timestamp":1687737600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,6,26]],"date-time":"2023-06-26T00:00:00Z","timestamp":1687737600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100008762","name":"Genome Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008762","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013062","name":"G\u00e9nome Qu\u00e9bec","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016328","name":"Fondation du cancer du sein du Qu\u00e9bec","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016328","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hum Genet"],"published-print":{"date-parts":[[2023,7]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Risk prediction models hold great promise to reduce the impact of cancer in society through advanced warning of risk and improved preventative modalities. These models are evolving and becoming more complex, increasingly integrating genetic screening data and polygenic risk scores as well as calculating risk for multiple types of a disease. However, unclear regulatory compliance requirements applicable to these models raise significant legal uncertainty and new questions about the regulation of medical devices. This paper aims to address these novel regulatory questions by presenting an initial assessment of the legal status likely applicable to risk prediction models in Canada, using the CanRisk tool for breast and ovarian cancer as an exemplar. Legal analysis is supplemented with qualitative perspectives from expert stakeholders regarding the accessibility and compliance challenges of the Canadian regulatory framework. While the paper focuses on the Canadian context, it also refers to European and U.S. regulations in this domain to contrast them. Legal analysis and stakeholder perspectives highlight the need to clarify and update the Canadian regulatory framework for Software as a Medical Device as it applies to risk prediction models. Findings demonstrate how normative guidance perceived as convoluted, contradictory or overly burdensome can discourage innovation, compliance, and ultimately, implementation. This contribution aims to initiate discussion about a more optimal legal framework for risk prediction models as they continue to evolve and are increasingly integrated into landscape for public health.<\/jats:p>","DOI":"10.1007\/s00439-023-02576-8","type":"journal-article","created":{"date-parts":[[2023,6,26]],"date-time":"2023-06-26T15:02:02Z","timestamp":1687791722000},"page":"981-994","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Regulating cancer risk prediction: legal considerations and stakeholder perspectives on the Canadian context"],"prefix":"10.1007","volume":"142","author":[{"given":"Palmira Granados","family":"Moreno","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8912-1906","authenticated-orcid":false,"given":"Terese","family":"Knoppers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ma\u2019n H.","family":"Zawati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Lang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bartha M.","family":"Knoppers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Wolfson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hermann","family":"Nabi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michel","family":"Dorval","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacques","family":"Simard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yann","family":"Joly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,6,26]]},"reference":[{"key":"2576_CR1","unstructured":"(2020) Artificial intelligence in EU medical device legislation. https:\/\/www.cocir.org\/fileadmin\/Position_Papers_2020\/COCIR_Analysis_on_AI_in_medical_Device_Legislation_-_Sept._2020_-_Final_2.pdf."},{"key":"2576_CR2","unstructured":"Ashwini A (2016) What is the difference between web service and web application? Quora. https:\/\/www.quora.com\/What-is-the-difference-between-web-service-and-web-application"},{"key":"2576_CR3","doi-asserted-by":"publisher","first-page":"4439","DOI":"10.1038\/s41467-020-18297-9","volume":"11","author":"N Barda","year":"2020","unstructured":"Barda N, Riesel D, Akriv A et al (2020) Developing a COVID-19 mortality risk prediction model when individual-level data are not available. Nat Commun 11:4439. https:\/\/doi.org\/10.1038\/s41467-020-18297-9","journal-title":"Nat Commun"},{"key":"2576_CR4","doi-asserted-by":"publisher","first-page":"E601","DOI":"10.1503\/CMAJ.212097","volume":"194","author":"DR Brenner","year":"2022","unstructured":"Brenner DR, Poirier A, Woods RR et al (2022) Projected estimates of cancer in Canada in 2022. CMAJ 194:E601\u2013E607. https:\/\/doi.org\/10.1503\/CMAJ.212097","journal-title":"CMAJ"},{"key":"2576_CR5","unstructured":"Health Canada (2011) Guidance document: Software regulated as medical device: Classification examples. Minister of Health, Ottawa. https:\/\/www.canada.ca\/en\/health-canada\/services\/drugs-health-products\/medical-devices\/application-information\/guidance-documents\/software-medical-device-guidance\/examples.html"},{"key":"2576_CR6","unstructured":"Health Canada (2015) Guidance document: Guidance on the risk-based classification system for non-in vitro diagnostic devices (non-IVDDs). Minister of Health, Ottawa. https:\/\/www.canada.ca\/en\/health-canada\/services\/drugs-health-products\/medical-devices\/application-information\/guidance-documents\/guidance-document-guidance-risk-based-classification-system-non-vitro-diagnostic.html"},{"key":"2576_CR7","unstructured":"Health Canada (2018a) Notice: Health Canada\u2019s approach to digital health technologies. https:\/\/www.canada.ca\/en\/health-canada\/services\/drugs-health-products\/medical-devices\/activities\/announcements\/notice-digital-health-technologies.html"},{"key":"2576_CR8","unstructured":"Health Canada (2018b) Scientific advisory panel on software as a medical device (SAP-SaMD) - questions. Minister of Health, Ottawa. https:\/\/www.canada.ca\/en\/health-canada\/services\/drugs-health-products\/medical-devices\/activities\/scientific-expert-advisory-panels\/software-medical-device\/questions-january-26-2018b.html"},{"key":"2576_CR9","unstructured":"Health Canada (2019a) Guidance document: Software as a medical device (SaMD): Definition and classification. Minister of Health, Ottawa. https:\/\/www.canada.ca\/en\/health-canada\/services\/drugs-health-products\/medical-devices\/application-information\/guidance-documents\/software-medical-device-guidance-document.html"},{"key":"2576_CR10","unstructured":"Health Canada (2019b) Consultation on draft document for software as medical device (SaMD). Minister of Health, Ottawa. https:\/\/www.canada.ca\/en\/health-canada\/services\/drugs-health-products\/public-involvement-consultations\/medical-devices\/software-medical-device-draft-guidance.html"},{"key":"2576_CR11","unstructured":"Health Canada (2019c) Guidance document: Pre\u2010market requirements for medical device cybersecurity. Minister of Health, Ottawa. https:\/\/www.canada.ca\/en\/health-canada\/services\/drugs-health-products\/medical-devices\/application-information\/guidance-documents\/cybersecurity\/document.html"},{"key":"2576_CR12","unstructured":"Health Canada (2021) Medical devices directorate. https:\/\/www.canada.ca\/en\/health-canada\/corporate\/about-health-canada\/branches-agencies\/health-products-food-branch\/medical-devices-directorate.html%3E."},{"key":"2576_CR13","unstructured":"European Commission (2015) Guidelines on medical devices. https:\/\/ec.europa.eu\/docsroom\/documents\/13053\/attachments\/1\/translations."},{"key":"2576_CR14","unstructured":"Drabiak K (2017) The impact of a developing regulatory framework governing LDTS in precision oncology: Re-envisioning the clinical risk assessment paradigm. J Heal Biomed Law 13:1\u201389. HeinOnline, https:\/\/heinonline.org\/HOL\/P?h=hein.journals\/jhbio13&i=15."},{"key":"2576_CR15","doi-asserted-by":"crossref","unstructured":"Drisko JW, Maschi T (2015) Qualitative content analysis. In: Drisko JW (eds) Content Analysis: Pocket Guides to Social Work Research Methods. Oxford University Press, Oxford. USA","DOI":"10.1093\/acprof:oso\/9780190215491.001.0001"},{"key":"2576_CR16","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1093\/ejcts\/ezy180","volume":"54","author":"SW Grant","year":"2018","unstructured":"Grant SW, Collins GS, Nashef SAM (2018) Statistical primer: Developing and validating a risk prediction model. Eur J Cardio-Thoracic Surg 54:203. https:\/\/doi.org\/10.1093\/ejcts\/ezy180","journal-title":"Eur J Cardio-Thoracic Surg"},{"key":"2576_CR17","unstructured":"International Medical Device Regulators Forum (IMDRF) SaMD Working Group (2013) Software as a medical device: Key definitions. https:\/\/www.imdrf.org\/sites\/default\/files\/docs\/imdrf\/final\/technical\/imdrf-tech-131209-samd-key-definitions-140901.pdf."},{"key":"2576_CR18","doi-asserted-by":"publisher","first-page":"736","DOI":"10.3390\/jpm11080736","volume":"11","author":"BM Knoppers","year":"2021","unstructured":"Knoppers BM, Bernier A, Moreno PG, Pashayan N (2021) Of screening, stratification, and scores. J Pers Med 11:736. https:\/\/doi.org\/10.3390\/jpm11080736","journal-title":"J Pers Med"},{"key":"2576_CR19","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1038\/bjc.2013.730","volume":"110","author":"AJ Lee","year":"2014","unstructured":"Lee AJ, Cunningham AP, Kuchenbaecker KB et al (2014) BOADICEA breast cancer risk prediction model: Updates to cancer incidences, tumour pathology and web interface. Br J Cancer 110:535\u2013545. https:\/\/doi.org\/10.1038\/bjc.2013.730","journal-title":"Br J Cancer"},{"key":"2576_CR20","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1038\/s41436-018-0406-9","volume":"21","author":"A Lee","year":"2019","unstructured":"Lee A, Mavaddat N, Wilcox AN et al (2019) BOADICEA: A comprehensive breast cancer risk prediction model incorporating genetic and nongenetic risk factors. Genet Med 21:1708\u20131718. https:\/\/doi.org\/10.1038\/s41436-018-0406-9","journal-title":"Genet Med"},{"key":"2576_CR21","unstructured":"(1998) Medical devices regulations. SOR\/98\u2013282. https:\/\/laws-lois.justice.gc.ca\/eng\/regulations\/sor-98-282\/"},{"key":"2576_CR22","unstructured":"(2017) Regulation (EU) 2017\/ 745 of the European Parliament and of the council - of 5 April 2017 - on medical devices, amending Directive 2001\/ 83\/ EC, Regulation (EC) No 178\/ 2002 and Regulation (EC) No 1223\/ 2009 and repealing Council Directives 90\/ 385\/ EEC. Off J Eur Union 5:1\u2013117. https:\/\/eur-lex.europa.eu\/legal-content\/EN\/TXT\/PDF\/?uri=CELEX:32017R0745"},{"key":"2576_CR23","unstructured":"RSC (1985) Food and Drugs Act, c F-27. https:\/\/laws-lois.justice.gc.ca\/eng\/acts\/f-27\/"},{"key":"2576_CR24","unstructured":"(2022) The software precertification (Pre-Cert) pilot program: Tailored total product lifecycle approaches and key findings. Food and Drug Agency. https:\/\/www.fda.gov\/medical-devices\/digital-health-center-excellence\/digital-health-software-precertification-pre-cert-pilot-program."},{"key":"2576_CR25","doi-asserted-by":"publisher","first-page":"1702","DOI":"10.1002\/humu.23621","volume":"39","author":"A Thorogood","year":"2018","unstructured":"Thorogood A, Tour\u00e9 SB, Ordish J et al (2018) Genetic database software as medical devices. Hum Mutat 39:1702\u20131712. https:\/\/doi.org\/10.1002\/humu.23621","journal-title":"Hum Mutat"},{"key":"2576_CR26","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1093\/intqhc\/mzm042","volume":"19","author":"A Tong","year":"2007","unstructured":"Tong A, Sainsbury P, Craig J (2007) Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups. Int J Qual Heal Care 19:349\u2013357. https:\/\/doi.org\/10.1093\/intqhc\/mzm042","journal-title":"Int J Qual Heal Care"},{"key":"2576_CR27","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.1038\/bjc.2015.409","volume":"113","author":"J Usher-Smith","year":"2015","unstructured":"Usher-Smith J, Emery J, Hamilton W et al (2015) Risk prediction tools for cancer in primary care. Br J Cancer 113:1645\u20131650. https:\/\/doi.org\/10.1038\/bjc.2015.409","journal-title":"Br J Cancer"},{"key":"2576_CR28","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1038\/s41586-021-03243-6","volume":"591","author":"H Wand","year":"2021","unstructured":"Wand H, Lambert SA, Tamburro C et al (2021) Improving reporting standards for polygenic scores in risk prediction studies. Nature 591:211\u2013219. https:\/\/doi.org\/10.1038\/s41586-021-03243-6","journal-title":"Nature"},{"key":"2576_CR29","doi-asserted-by":"publisher","first-page":"19","DOI":"10.4137\/CIN.S13788","volume":"13","author":"X Wang","year":"2014","unstructured":"Wang X, Oldani MJ, Zhao X et al (2014) A review of cancer risk prediction models with genetic variants. Cancer Inform 13:19\u201328. https:\/\/doi.org\/10.4137\/CIN.S13788","journal-title":"Cancer Inform"},{"key":"2576_CR30","unstructured":"Web service vs web application (2016) Stack Overflow. https:\/\/www.quora.com\/What-is-the-difference-between-web-service-and-web-application."}],"container-title":["Human Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00439-023-02576-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00439-023-02576-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00439-023-02576-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,8]],"date-time":"2023-07-08T09:05:04Z","timestamp":1688807104000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00439-023-02576-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,26]]},"references-count":30,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2023,7]]}},"alternative-id":["2576"],"URL":"https:\/\/doi.org\/10.1007\/s00439-023-02576-8","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-2588059\/v1","asserted-by":"object"}]},"ISSN":["0340-6717","1432-1203"],"issn-type":[{"value":"0340-6717","type":"print"},{"value":"1432-1203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,26]]},"assertion":[{"value":"14 February 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study involving human participants was reviewed and approved by the Research Ethics Board of McGill University\u2019s Faculty of Medicine (IRB Study Number A03-B14-19A). Informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}